参考文献/References:
[1] Chaturvedi S, Yadav JS. The role of antiplatelet therapy in carotidstenting for ischemic stroke prevention[J]. Stroke, 2006, 37: 1572 - 1577.
[2] Kim MS, Dean LS. In-stent restenosis[J]. Cardiovasc Ther, 2011, 29: 190 - 198.
[3] Sprague EA. In vivo cardiovascular assays for drug discovery: evolution of the drug-eluting stent[J]. Curr Opin Investig Drugs, 2007, 8: 219 - 225.
[4] Ge H, Zhou Y, Hanying M, et al. Influence of drug-eluting stent on inflammation during restenosis in a porcine coronary model[J]. Acta Cardiol, 2010, 65: 31 - 35.
[5] Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents[J]. N Engl J Med, 2007, 356: 1020 - 1029.
[6] Loirand G, Guerin P, Pacaud P, et al. Rho kinases in cardiovascular physiology and pathophysiology[J]. Circ Res, 2006, 98: 322 - 334.
[7] Huang Y, Venkatraman SS, Boey FY, et al. In vitro and in vivo performance of a dual drug-eluting stent(DDES)[J]. Bioma-terials, 2010, 31: 4382 - 4391.
[8] Iso Y, Suzuki H, Sato T, et al. Rho-kinase inhibitor suppressed restenosis in porcine coronary balloon angioplasty[J]. Int J Cardiol, 2006, 106: 103 - 110.
[9] Dong M, Yan BP, Liao JK, et al. Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases[J]. Drug Discov Today, 2010, 15: 622 - 629.
[10] Shimokawa H, Rashid M. Development of Rho-kinase inhibitors for cardiovascular medicine[J]. Trends Pharmacol Sci, 2007, 28: 296 - 302.
[11] Shimokawa H, Takeshita A. Rho-kinase is an important thera-peutic target in cardiovascular medicine[J]. Arterioscler Thromb Vasc Biol, 2005, 25: 1767 - 1775.
[12] Matsumoto Y, Uwatoku T, Oi K, et al. Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms[J]. Arterioscler Thromb Vasc Biol, 2004, 24: 181 - 186.
[13] Seasholtz TM, Zhang T, Morissette MR, et al. Increased expression and activity of RhoA are associated with increased DNA synthesis and reduced p27(Kip1) expression in the vasculature of hypertensive rats[J]. Circ Res, 2001, 89: 488 - 495.
[14] Guérin P, Sauzeau V, Rolli-Derkinderen M, et al. Stent implan-tation activates RhoA in human arteries: inhibitory effect of rapamycin[J]. J Vasc Res, 2005, 42: 21 - 28.
[15] Halayko AJ, Solway J. Molecular mechanisms of phenotypic plasticity in smooth muscle cells[J]. J Appl Physiol, 2001: 358 - 368.
[16] 关启刚, 曾定尹, 孙喜琢, 等. Rho激酶在小型猪白介素-1β介导的冠状动脉痉挛中的作用机制[J]. 中华心血管病杂志, 2006, 34: 50 - 53.
[17] Chung IM, Gold HK, Schwartz SM, et al. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment[J]. J Am Coll Cardiol, 2002, 40: 2072 - 2081.
[18] Libby P, Edelman E. Restenosis:involvement of growth factors and cytokines. Topol EJ, eds. Textbook of Interventional Cardiology[M]. 3rd ed. Philadelphia, Pa: Saunders, 1999: 346 - 357.
[19] Ward MR, Agrotis A, Kanellakis P, et al. Tranilast prevents activation of transforming growth factor-beta system, leukocyte accumulation, and neointimal growth in porcine coronary arteries after stenting[J]. Arterioscler Thromb Vasc Biol, 2002, 22: 940 - 948.
[20] Li C, Cantor WJ, Nili N, et al. Arterial repair after stenting and the effects of GM6001, a matrix metalloproteinase inhibitor[J]. J Am Coll Cardiol, 2002, 39: 1852 - 1858.
[21] Chamberlain J. Transforming growth factor-beta: a promising target for anti-stenosis therapy[J]. Cardiovasc Drug Rev, 2001, 19: 329 - 344.
[22] Fleming IN, Elliott CM, Exton JH. Differential translocation of rho family GTPases by lysophosphatidic acid, endothelin-1, and platelet-derived growth factor[J]. J Biol Chem, 1996, 271: 33067 - 33073.
[23] Richter GM, Palmaz JC, Noeldge G, et al. Relationship between blood ow, thrombus, and neointima in stents[J]. J Vasc Interv Radiol, 1999: 598 - 604.
[24] Nakakuki T, Ito M, Iwasaki H, et al. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells[J]. Arterioscler Thromb Vasc Biol, 2005, 25: 2088 - 2093.
[25] Gunnarsson P, Levander L, Phlsson P, et al. Alpha(1)-acid glycoprotein (AGP)-induced platelet shape change involves the Rho/Rho kinase signalling pathway[J]. Thromb Haemost, 2009, 102: 694 - 703.
[26] Hirooka Y, Shimokawa H. Therapeutic potential of rho-kinase inhibitors in cardiovascular diseases[J]. Am J Cardiovasc Drugs, 2005, 5: 31 - 39.
相似文献/References:
[1]张 琳,黄学全,王健,等.自主研发电化学治疗同轴电极与传统针式电极电解效应的对比研究[J].介入放射学杂志,2012,(02):148.
ZHANG Lin,HUANG Xue-quan,WANG Jian,et al.The electrolytic effect in electrochemotherapy: a comparative study between self-prepared coaxial electrode and conventional needle electrode[J].journal interventional radiology,2012,(02):148.
[2]赵 玮,王伟中,陈莹,等.耳部动静脉畸形供血动脉的血管造影研究[J].介入放射学杂志,2012,(02):103.
ZHAO Wei,WANG Wei-zhong,CHEN Ying,et al.Angiographic findings of the feeding arteries of auricular arteriovenous malformations[J].journal interventional radiology,2012,(02):103.
[3]邹俊民,龙世娟,张振明. 改良髂内动脉化疗联合放疗治疗Ⅲ~Ⅳa期 子宫颈癌32例[J].介入放射学杂志,2012,(02):123.
ZOU Jun-min,LONG Shi-Juan,ZHANG Zheng-ming..Improved internal iliac artery chemotherapy combined with radiotherapy for the treatment of stage Ⅲ-Ⅳa cervical cancers[J].journal interventional radiology,2012,(02):123.
[4]王昌明,李 选,宋世兵,等.肝门部胆道引流管折叠技术在肝移植后胆道非吻合口狭窄治疗中的应用[J].介入放射学杂志,2012,(02):136.
WANG Chang-ming,LI Xuan,SONG Shi-bing,et al.The application of biliary catheter folding technique in the treatment of hilar nonanastomotic biliary strictures after orthotopic liver transplantation[J].journal interventional radiology,2012,(02):136.
[5]赵玉峰,孙玉琴,韩晓静,等. 输卵管介入再通术后受孕时机的研究[J].介入放射学杂志,2012,(02):158.
ZHAO Yu-feng,SUN Yu-qin,HAN Xiao-jing,et al.The optimal time for conception after fallopian tube recanalization therapy[J].journal interventional radiology,2012,(02):158.
[6]含 笑,曹建民,史东宏,等.吉西他滨、顺铂动静脉联合化疗治疗晚期非小细胞肺癌的近期疗效分析[J].介入放射学杂志,2012,(02):119.
HAN Xiao,CAO Jian-min,SHI Dong-hong,et al.Bronchial artery infusion of Gemcitabine and Cisplatin combined with systemic chemotherapy for advanced non-small cell lung cancer: its short-term efficacy[J].journal interventional radiology,2012,(02):119.
[7]姚雪松,李 槐.不可手术切除的肝细胞癌的疗效评价标准——改良ＲＥＣＩＳＴ标准更可靠[J].介入放射学杂志,2012,(03):177.
. Ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ ｃｒｉｔｅｒｉｏｎ ｏｆ ｉｎｏｐｅｒａｂｌｅ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ｍｏｄｉｆｉｅｄ ＲＥＣＩＳＴ ａｓ ａ ｍｏｒｅ ｒｅｌｉａｂｌｅ ｓｔａｎｄａｒｄ[J].journal interventional radiology,2012,(02):177.
[8]齐 立,李慎茂,俸军林,等. 动脉溶栓与机械碎栓联合动脉溶栓的对比分析[J].介入放射学杂志,2012,(03):180.
,,et al. Ｃｏｍｐａｒｉｓｏｎ ｏｆ ｔｈｅ ｔｈｅｒａｐｅｕｔｉｃ ｅｆｆｉｃａｃｙ ｂｅｔｗｅｅｎ ｓｉｍｐｌｅ ａｒｔｅｒｉａｌ ｔｈｒｏｍｂｏｌｙｓｉｓ ａｎｄ ｍｅｃｈａｎｉｃａｌ ｔｈｒｏｍｂｅｃｔｏｍｙ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ａｒｔｅｒｉａｌ ｔｈｒｏｍｂｏｌｙｓｉｓ ｆｏｒ ａｃｕｔｅ ｃｅｒｅｂｒａｌ ｉｎｆａｒｃｔｉｏｎ ａｔ ｉｔｓ ｕｌｔｒａｅａｒｌｙ ｓｔａｇｅ[J].journal interventional radiology,2012,(02):180.
[9]石 潆,赵 卫,沈 进,等.脑动静脉畸形栓塞治疗术并发颅内出血的原因及处理[J].介入放射学杂志,2012,(03):185.
,,et al.Ｉｎｔｒａｃｒａｎｉａｌ ｈｅｍｏｒｒｈａｇｅ ｄｕｅ ｔｏ ｅｍｂｏｌｉｚａｔｉｏｎ ｔｈｅｒａｐｙ ｆｏｒ ｃｅｒｅｂｒａｌ ａｒｔｅｒｉｏｖｅｎｏｕｓ ｍａｌｆｏｒｍａｔｉｏｎ： ｉｔｓ ｃａｕｓｅｓ ａｎｄ ｍａｎａｇｅｍｅｎｔ [J].journal interventional radiology,2012,(02):185.
[10]周 慷,李晓光,金征宇,等.清宫术前子宫动脉化疗栓塞术治疗瘢痕妊娠的疗效分析[J].介入放射学杂志,2012,(03):190.
,,et al.Ｔｈｅｒａｐｅｕｔｉｃ ａｎａｌｙｓｉｓ ｏｆ ｂｉｌａｔｅｒａｌ ｕｔｅｒｉｎｅ ａｒｔｅｒｙ ｃｈｅｍｏｅｍｂｏｌｉｚａｔｉｏｎ ｐｅｒｆｏｒｍｅｄ ｂｅｆｏｒｅ ｕｔｅｒｉｎｅ ｄｉｌａｔｉｏｎ ａｎｄ ｃｕｒｅｔｔａｇｅ ｆｏｒ ｃｅｓａｒｅａｎ ｓｃａｒ ｐｒｅｇｎａｎｃｙ [J].journal interventional radiology,2012,(02):190.